Aware Super Pty Ltd as trustee of Aware Super Purchases Shares of 2,115 DaVita Inc. (NYSE:DVA)

Aware Super Pty Ltd as trustee of Aware Super bought a new stake in DaVita Inc. (NYSE:DVA) during the fourth quarter, HoldingsChannel reports. The fund bought 2,115 shares of the company’s stock, valued at approximately $316,000.

A number of other institutional investors have also modified their holdings of the stock. SBI Securities Co. Ltd. purchased a new position in DaVita during the fourth quarter worth approximately $41,000. Canada Post Corp Registered Pension Plan acquired a new position in DaVita in the fourth quarter valued at approximately $55,000. Venturi Wealth Management LLC boosted its stake in DaVita by 59.8% during the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock worth $61,000 after buying an additional 152 shares during the period. Versant Capital Management Inc raised its holdings in shares of DaVita by 58.7% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $68,000 after buying an additional 169 shares during the period. Finally, Blue Trust Inc. increased its stake in DaVita by 39.7% during the 4th quarter. Blue Trust Inc. now owns 461 shares of the company’s stock worth $76,000 after buying an additional 131 shares during the period. Hedge funds and other institutional investors own 90.12% of the company’s stock.

DaVita Stock Down 3.2 %

DVA opened at $146.11 on Wednesday. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26. The business’s fifty day moving average is $151.09 and its two-hundred day moving average is $156.44. DaVita Inc. has a one year low of $125.64 and a one year high of $179.60. The company has a market cap of $11.69 billion, a price-to-earnings ratio of 13.60, a PEG ratio of 1.07 and a beta of 1.04.

DaVita (NYSE:DVA) last released its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. Analysts anticipate that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on DVA. StockNews.com raised DaVita from a “hold” rating to a “buy” rating in a research report on Thursday, April 10th. Cowen reiterated a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. Barclays raised their price target on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 price objective on shares of DaVita in a research report on Friday, February 21st. One analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $166.33.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.